Jeff Leerink's journey is a remarkable one, marked by a significant shift in his career trajectory. He was instrumental in the sale of SVB Leerink to SVB Financial Group.
The sale was a pivotal moment for Leerink, allowing him to refocus his efforts on business revival. His experience and expertise in the field made him an ideal candidate to spearhead this effort.
With a renewed sense of purpose, Leerink dove headfirst into his new role, leveraging his knowledge to drive growth and innovation. His dedication and perseverance paid off, as he successfully revitalized the business.
Leerink's perseverance in the face of adversity is a testament to his unyielding commitment to his work.
Readers also liked: Leerink Partners
Jeff Leerink
Jeff Leerink is the Chairman and Chief Executive Officer of Leerink Partners, the largest independent investment bank dedicated exclusively to healthcare.
Under his leadership, Leerink Partners has earned a reputation as a trusted partner to healthcare clients and investors, helping them achieve their strategic and financial objectives in a complex, rapidly evolving industry.
Take a look at this: Leerink Astrazeneca
Mr. Leerink co-founded MEDACorp in 1996, a provider of insights on the commercial potential of biotherapeutics and medical devices to healthcare companies and investors.
MEDACorp continues to provide industry and market insights to Leerink Partners and its clients to this day.
In 2008, he co-founded Humedica, Inc., a clinical intelligence company that was later acquired by Optum, a subsidiary of UnitedHealth Group, in 2013.
Mr. Leerink also founded Leerink Capital Partners in 2013, a healthcare-focused, multi-strategy asset management firm.
Its private equity funds were integrated into SVB Capital in 2019.
Mr. Leerink led the sale of Leerink Partners to Silicon Valley Bank in 2019.
He served as CEO of SVB Securities until 2023, when he led a successful management buyout, restoring Leerink Partners’ independence.
Mr. Leerink holds a B.A. in Economics from Union College.
Explore further: Healthcare Asset Management Companies
Frequently Asked Questions
How much did SVB buy Leerink for?
SVB acquired Leerink for a total of $340 million, consisting of $280 million upfront and a $60 million retention pool for employees. This significant investment marked a major milestone in SVB's expansion.
Who is the CEO of Leerink?
The CEO of Leerink is Jeffrey A. Leerink, who also serves as Chairman. He leads Leerink Partners, the largest independent investment bank focused on healthcare.
Sources
- https://www.leerink.com/team/jeffrey-a-leerink/
- https://www.linkedin.com/in/jeffrey-leerink-b13a231
- https://www.leerink.com/firm/
- https://www.financemagnates.com/institutional-forex/leerink-sold-his-business-for-280m-to-svb-now-buys-it-back-for-100m/
- https://worldbusinessoutlook.com/jeff-leerink-group-to-acquire-svb-securities-from-svb-financial-group/
Featured Images: pexels.com
